MTB vs URGN · P/E 12, rev $860.0M vs rev $123.4M
M&T Bank Corporation (MTB) versus UroGen Pharma Ltd (URGN) — a side-by-side from cached financials, not a winner call.
M&T Bank Corporation (MTB) is a banks - regional company listed on US.
UroGen Pharma Ltd (URGN) is a biotechnology company listed on NASDAQ.
Latest reported MTB revenue for 2026-06-30 was $860.0M. Net income was $1.48B. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
Latest reported URGN revenue for 2026-06-30 was $123.4M. Net income was -$37.9M. URGN currently screens at market cap $1.61B.
MTB currently screens at market cap $30.99B and trailing P/E 11.9. URGN currently screens at market cap $1.61B.
Not investment advice. Open the MTB and URGN stock pages for the full models.
Not investment advice.